Ascendis Pharma

Ascendis Pharma is a biopharmaceutical company that applies its innovative TransCon technology to create new and potentially best-in-class therapies. The company’s focus is on developing treatments for rare diseases, endocrinology, and oncology. Ascendis Pharma’s pipeline includes multiple product candidates in various stages of development, including clinical trials. The company aims to address unmet medical needs by improving the efficacy, safety, and convenience of existing treatments. Ascendis Pharma collaborates with leading healthcare professionals and organizations to advance its research and development efforts. The company is committed to making a meaningful difference in the lives of patients through its scientific expertise and dedication to innovation. Ascendis Pharma’s headquarters are located in Denmark, with additional offices in the United States and Germany. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol ASND.